Interferon beta1a therapy changes lipoprotein metabolism in patients with multiple sclerosis.
Sena, A
Interferon beta1a therapy changes lipoprotein metabolism in patients with multiple sclerosis. [electronic resource] - Clinical chemistry and laboratory medicine Mar 2000 - 209-13 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1434-6621
10.1515/CCLM.2000.030 doi
Adult
Apolipoprotein A-I--blood
Female
Follow-Up Studies
Humans
Interferon beta-1a
Interferon-beta--therapeutic use
Lipoproteins--blood
Lipoproteins, HDL--blood
Lipoproteins, HDL2
Lipoproteins, HDL3
Male
Middle Aged
Multiple Sclerosis--blood
Recurrence
Time Factors
Interferon beta1a therapy changes lipoprotein metabolism in patients with multiple sclerosis. [electronic resource] - Clinical chemistry and laboratory medicine Mar 2000 - 209-13 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1434-6621
10.1515/CCLM.2000.030 doi
Adult
Apolipoprotein A-I--blood
Female
Follow-Up Studies
Humans
Interferon beta-1a
Interferon-beta--therapeutic use
Lipoproteins--blood
Lipoproteins, HDL--blood
Lipoproteins, HDL2
Lipoproteins, HDL3
Male
Middle Aged
Multiple Sclerosis--blood
Recurrence
Time Factors